What is the recommended treatment for a patient with a symptomatic or large aneurysm, specifically regarding Endoaneurysmorrhaphy (endoaneurysm repair)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Endoaneurysmorrhaphy: Treatment Recommendations

Overview

Endoaneurysmorrhaphy is the procedure of choice for symptomatic left ventricular aneurysms, offering low perioperative mortality (5-5.7%), significant improvement in functional status, and excellent medium-term survival rates. 1, 2

This surgical technique involves opening the aneurysm sac and reconstructing the ventricular chamber from within, as opposed to simple exclusion or resection approaches.

Clinical Indications

Symptomatic Left Ventricular Aneurysms

  • Endoaneurysmorrhaphy should be performed for all symptomatic ventricular aneurysms, particularly in patients with heart failure symptoms (NYHA class III or higher). 2
  • The procedure results in significant amelioration of cardiac clinical status, with median NYHA class improving from III preoperatively to II postoperatively (p < 0.001). 2

Location Considerations

  • Anterior-septal left ventricular aneurysms are the most common indication and carry lower surgical risk. 1
  • Posterior left ventricular aneurysms can be treated with endoaneurysmorrhaphy but carry higher perioperative mortality (p=0.017), likely due to more severe baseline heart failure and larger ventricular volumes. 1
  • Patients with posterior aneurysms present with higher LV end-diastolic volume index (138±38 vs. 102±41 ml/kg; p=0.040) compared to anterior-septal locations. 1

Surgical Outcomes and Prognosis

Short-Term Results

  • Perioperative mortality ranges from 5.0% to 5.7%, which is acceptably low for this high-risk population. 1, 2
  • Concomitant mitral valve surgery (p=0.008) and prolonged extracorporeal circulation time (p=0.001) are significant predictors of higher perioperative mortality. 1

Medium to Long-Term Outcomes

  • Annual mortality during follow-up is 3.3% per year, with 5-year survival rate of 78%. 2
  • Preexisting arterial occlusive disease and advanced age (>70 years) are significant predictors of medium-term mortality on multivariate analysis. 2
  • Implantation of the left internal mammary artery during concomitant coronary revascularization is associated with better survival rates. 2

Critical Technical Considerations

Superiority Over Exclusion Techniques

  • Endoaneurysmorrhaphy is recommended over simple ligation and exclusion when technically feasible. 3
  • Excluded aneurysms without resection frequently expand over time: 32% increase in size (mean 5.9 mm), 20% remain unchanged, and only 48% decrease in size during follow-up. 3
  • Contrast enhancement (analogous to type II endoleak) occurs in 44% of excluded aneurysm sacs, potentially leading to continued expansion and symptoms. 3

Surgical Approach

  • Complete aneurysm excision or endoaneurysmorrhaphy should be performed rather than simple exclusion to prevent late complications including continued expansion and potential rupture. 3
  • The technique involves opening the aneurysm sac, removing thrombus, and reconstructing the ventricular geometry from within using endocardial sutures. 2

Patient Selection Algorithm

Favorable Candidates

  • Symptomatic patients with NYHA class II-IV heart failure 2
  • Age <70 years (better medium-term survival) 2
  • Absence of severe peripheral arterial occlusive disease 2
  • Anterior-septal aneurysm location (lower surgical risk) 1

Higher Risk Patients (Requires Careful Individualized Assessment)

  • Age >70 years (significant predictor of mortality) 2
  • Posterior LV aneurysm location (higher perioperative mortality) 1
  • Severe heart failure with markedly elevated LV end-diastolic volumes 1
  • Need for concomitant mitral valve surgery (p=0.008 for mortality) 1

Important Caveats

  • The presence of a posterior LV aneurysm is independently associated with higher perioperative mortality, though this may be confounded by more severe baseline heart failure in these patients. 1
  • Concomitant coronary revascularization with internal mammary artery grafting should be performed when indicated, as it improves long-term survival. 2
  • Simple exclusion without resection is inadequate and leads to continued aneurysm expansion in one-third of cases, similar to endotension after endovascular aortic repair. 3

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.